Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Net Change in Cash : ₺-405 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Net Change in Cash for the three months ended in Dec. 2023 was ₺-915 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was ₺-405 Mil.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Net Change in Cash Historical Data

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Net Change in Cash Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

24.48

4.97

460.79

-245.82

-404.51

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
	Dec18	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Change in Cash	Get a 7-Day Free Trial												-422.26	443.63	-50.91	117.32	-914.54

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Net Change in Cash Calculation

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	177.348	+	-648.233	+	66.38	+	0
	=	-405

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -178.881 + -253.723 + -481.936 + 0

= -915

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺-405 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) » Definitions » Net Change in Cash

Comparable Companies

IST:DEVA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NBIX NSE:DIVISLAB BOM:500124 VTRS SZSE:000963 XPAR:IPN SHSE:600085 XTAE:TEVA SHSE:600196

Traded in Other Exchanges

N/A

Address

Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520

Website

https://www.genilac.com.tr

Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Headlines

No Headlines